TCG Crossover GP II, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Tango Therapeutics, Inc. Common Stock, par value $0.001 per share (TNGX)

Filing Manager
TCG Crossover GP II, LLC
Reporting Manager
TCG Crossover GP II, L.P.
Security
Tango Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
TNGX
Shares outstanding
135,353,744 shares
Disclosed Ownership
13,521,839 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:22:39 UTC
Date of event
31 Dec 2025
Previous filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP II, L.P. 10% 13,521,839 0 13,521,839 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund II, L.P. 10% 13,521,839 0 13,521,839 /s/ Craig Skaling Craig Skaling, Authorized Signatory
Chen Yu 10% 13,521,839 0 13,521,839 /s/ Craig Skaling Craig Skaling, as Attorney-in-Fact for Chen Yu